spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, N.
Right arrow Articles by Dey, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, N.
Right arrow Articles by Dey, C. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells

Naresh Kumar and Chinmoy S. Dey*

Signal Transduction Research Laboratory, Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Punjab, India



View larger version (33K):

[in a new window]
 
Fig. 1. Effect of the chronic presence of insulin and gliclazide on tyrosine phosphorylation of insulin receptor ß (IR-ß) in C2C12 myotubes. Gliclazide (2 mmol l-1) was added during the last day of differentiation for 24 h to C2C12 cells differentiated in the absence (MF) or in the chronic presence (MFI) of insulin. The cells were then stimulated with 100 nmol l-1 insulin for 5 min and lysed. Cell lysate was immunoprecipitated (IP) with antibodies against IR-ß and western immunoblotted (IB) with anti-phosphotyrosine (pTyr) antibody (A). The blots were stripped and reprobed with IR-ß (B). Experiments were repeated three times and representative blots are shown. Phosphorylation levels of IR (C) were quantified by densitometry and expressed relative to MF (control) samples. Error bars represent the S.E.M. of three independent experiments (*P<0.05).

 


View larger version (29K):

[in a new window]
 
Fig. 2. Effect of the chronic presence of insulin and gliclazide on tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1) in C2C12 myotubes. Samples were treated as described in Fig. 1. Cell lysate was immunoprecipitated (IP) with antibodies against IRS-1 and western immunoblotted (IB) with anti-phosphotyrosine (pTyr) antibody (A). The blots were stripped and reprobed with IRS-1 (B). Experiments were repeated three times and representative blots are shown. Phosphorylation levels of IRS-1 (C) were quantified by densitometry and expressed relative to MF (controls, differentiated in the absence of insulin) samples. Error bars represent the S.E.M. of three independent experiments (**P<0.01). MFI, cells differentiated in the chronic presence of insulin.

 


View larger version (21K):

[in a new window]
 
Fig. 3. Effect of the chronic presence of insulin and gliclazide on phosphatidylinositol 3-kinase (PI 3-kinase) activity in C2C12 myotubes. C2C12 cells, differentiated in the absence (MF) or in the chronic presence (MFI) of insulin, were washed with Krebs-Ringer phosphate (KRP) buffer as described in Materials and methods, followed by stimulation with insulin (100 nmol l-1) for 10 min. PI 3-kinase activity in anti-IRS-1 (insulin receptor substrate 1) immunoprecipitates was measured as described under Materials and methods. Cells were treated with 2 mmol l-1 gliclazide during the last 24 h of differentiation. A representative autoradiogram for three independent experiments is shown (A). The relative density of phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] spots (B) was quantified by densitometry and expressed relative to control samples (unstimulated insulin samples). Error bars represent the S.E.M. of three independent experiments (*P<0.05).

 


View larger version (16K):

[in a new window]
 
Fig. 4. Effect of the chronic presence of insulin and gliclazide on 2-deoxyglucose (2-DOG) uptake in C2C12 myotubes. C2C12 cells, differentiated in the absence (MF) or in the chronic presence (MFI) of insulin, were washed with Krebs-Ringer phosphate (KRP) buffer as described in Materials and methods, followed by stimulation with insulin (100 nmol l-1) for 15 min. [3H]2-DOG uptake was measured as described in Materials and methods. Cells were treated with 2 mmol l-1 gliclazide during the last 24 h of differentiation. Error bars represent the S.E.M. of four independent experiments (*P<0.05).

 


View larger version (39K):

[in a new window]
 
Fig. 5. Effect of the chronic presence of insulin and gliclazide on extracellular-signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 activation. C2C12 cells, differentiated in the absence (MF) or in the chronic presence (MFI) of insulin, were washed with Krebs-Ringer phosphate (KRP) buffer as described in Materials and methods, followed by stimulation with insulin (100 nmol l-1) for 5 min. Lysates were prepared from cells treated with 2 mmol l-1 gliclazide during the last 24 h of differentiation. Protein was resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with phospho-specific ERK (pERK) (A), phospho-specific JNK (pJNK) (D), phospho-specific p38 (pp38) (G), ERK (B), JNK (E), p38 (H) antibodies. Phospho-specific blots are representative of experiments performed three times. Error bars of quantified data for pERK (C), pJNK (F) and pp38 (I) represent the S.E.M. of three independent experiments.

 


View larger version (30K):

[in a new window]
 
Fig. 6. Effect of SB203580 on 2-deoxyglucose (2-DOG) uptake and p38 activation. C2C12 cells, differentiated in the absence (MF) or in the chronic presence (MFI) of insulin, were incubated in Krebs-Ringer phosphate (KRP) buffer for 30 min followed by another incubation of 30 min in the presence of 10 µmol l-1 SB203580. Cells were stimulated with 100 nmol l-1 insulin in the presence of SB203580, followed by 2-DOG uptake for 10 min (A) or immunoblot analysis of p38 activation (B). Cells were treated with 2 mmol l-1 gliclazide during the last 24 h of differentiation. Error bars represent the S.E.M. of three independent experiments.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2002